G/MA/QR/N/KGZ/1/Add.7  
21 de abril de 2021 
(21-3427) Página: 1/10 
Comité de Acceso a los Mercados  Original:  inglés  
 
  
NOTIFICACIÓN DE CONFORMIDAD CON LA DECISIÓN SOBRE EL  
PROCEDIMIENTO DE NOTIFICACIÓN DE RESTRICCIONES  
CUANTITATIVAS (G/L/59/REV.1)  
REPÚBLICA KIRGUISA  
Addendum  
La siguiente comunicación, de fecha 9 de abril de 2021 , recibida el 20 de abril de 2021 , se distribuye 
a petición de la delegación de la República Kirguisa . 
 
A. Miembro notificante : la República Kirguisa  
B. Fecha de la notificación : 9 de abril de 2021  
C. Primera notificación:  
 Sí 
 No, la última notificación se presentó con la signatura (signatura del documento) : 
G/MA/QR/N/KGZ/1/Add. 6 
D. Tipo de notificació n: 
 1. Completa (es decir, notificación de todas las restricciones cuantitativas en vigor)  
 2. Cambios de una notificación presentada anteriormente con la signatura  
G/MA/QR/N/KGZ/1 consistentes en lo siguiente:  
 2.1 Establecimiento de nuevas restricciones, enumeradas en la sección 1.  
 2.2 Eliminación de restricciones, como se describe e n la casilla G infra. 
 2.3 Modificación de una restricción notificada anteriormente, como se indica en la  
sección 1.  
 3. Notificación inversa de restricciones mantenidas por (Miembro):  
E. La notificación proporciona información sobre el siguiente período bienal 
(por ejemplo, 2012 -2014) : 2020-2022 y se refiere a restricciones en vigor al  22 de 
marzo  de 2021  
F. La presente notificación contiene información* relativa a:  
 Sección 1:  Lista de restricciones cuantitativas actualmente en vigor.  
 Sección 2:  Referencia a otras notificaciones presentadas a la OMC que contengan 
información sobre restricciones cuantitativas actualmente en vigor e 
información adicional.  
 
* En inglés solamente.  G/MA/QR/N/KGZ/1/Add.7  
- 2 - 
  G. Observaciones de carácter general, con inclusión de una descripción de la 
eliminación de restricciones notificada en el apartado 2.2 de la casilla D y la fecha 
en que esas restricciones dejaron de estar en vigor.  
De conformidad con el Decreto del Gobierno de la República Kirguisa N º 136, de fecha 9 de 
abril de 2021 , la restricción temporal a la exportación de medicamentos y productos médicos  
entró en vigor el 12 de abril de 2021. E sta medida temporal se ha introducido en respuesta 
a la pandemia de COVID -19. Si la República Kirguisa adopta medidas adicio nales, presentará 
una notificación pertinente.    
  G/MA/QR/N/KGZ/1/Add.7  
 
- 3 - Section 1: List of quantitative restrictions that are currently in force  
 
No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed 
Product 
Description  WTO Justification and 
Grounds for Restriction, 
e.g., Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modify  
cation of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
1 Export prohibition of  
medicines and 
medical products  P-X 3004 20 000 2  Azithromycin  GATT Article XI:(2)(a)  
 
GATT Article XX(b)  
 Decree of 
Government of the 
Kyrgyz Republic 
#136 dated 
09.04.2021  
 
 The Government of the Kyrgyz 
Republic adopted decree #136, 
dated 09.04.2021, on the 
introduction of a temporary ban 
for six months  on medicines and 
medical products from the 
Kyrgyz Republ ic. The 
abovementioned decree entered 
into force on 12.04.2021.  
 
The measure is valid until 
14.10.2021  
 
It is necessary to follow both the 
HS code and the name of 
medicines and medical products;  
 
Exports for the purpose of 
humanitarian assistance are 
excluded from this export 
restriction.  
 
Export of the following medicines 
and medical goods classified 
under the EAEU HS codes is 
allowed on the basis of:  
- the conclusion on the 
purposefulness of export issued 
by the Ministry of Health and 
Social Development of the 
Kyrgyz Republic for each batch of 
exported goods, containing 
information on the 
nomenclature, quantity, value of 
such goods, as well as on the 
organizations that carry out the 
export;  
   
  G/MA/QR/N/KGZ/1/Add.7  
 
- 4 - No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed 
Product 
Description  WTO Justification and 
Grounds for Restriction, 
e.g., Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modify  
cation of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
       - the presence of a certificate of 
origin of the goods in the Kyrgyz 
Republic.  
 
Azithromycin - HS code 3004 20 
000 2;  
Ampicillin - HS code 3004 10 000;  
Acetylsalicylic acid - HS code 
3004 90 000 6;  
Paracetamol - HS code 3004 90 
000 2;  
Ceftriaxone - HS code 3004 20 
000 2;  
Cefepim - HS code 3004 20 000 
2; 
Medical protective suit -HS code 
6210 10 980 0;  
Medical dressing gown, 
disposable – HS codes 6203 39 
900 0; 6211 49 000 9; 6211 32 
100 0; 6210 10 980 0; 6211 43 
100 0;  
Masks, half masks, respirator 
masks, respirator - HS codes  
3005 90 500 0, 4818 90 100 0, 
4818 90 900 and 6307 90 980;  
   3004 90 000 2 Ambroxol     
   3004 20 000 1  Amikacin     
   3004 10 000 5  Amoxicillin     
   3004 10 000 5  Amoxicillin + 
clavulanic acid     
   3004 10 000 1  Ampicillin     
   3004 90 000 2  Apixaban     
   3004 90 000 6  Acetylsalicylic 
acid    
   3004 90 000 2  Acetylcysteine     
   3004 32 000 9  Betamethasone     
   3004 90 000 2  Bromhexine     
   3004 90 000 2  Butamirat     
   3004 90 000 2  Vasopressin       
  G/MA/QR/N/KGZ/1/Add.7  
 
- 5 - No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed 
Product 
Description  WTO Justification and 
Grounds for Restriction, 
e.g., Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modify  
cation of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   3004 20 000 2  Vancomycin     
   3004 90 000 2  Heparin     
   3004 32 000 9  Hydrocortisone     
   3004 90 000 2  Dabigatran     
   3004 90 000 2  Dalteparin 
sodium     
   3004 32 000 9  Dexamethasone     
   3004 90 000 2  Diazepam     
   3004 90  000 2  Diphenhydramin
e    
   3004 90 000 2  Dobutamine     
   3004 90  000 2  Domperidone     
   3004 39 000  Dopamine     
   3004 90 000 2  Ibuprofen     
   3004 90 000 2  Isotonic sodium 
chloride solution 
(0.9%)     
   3004 20 000 2  Imipenem     
   3004 90  000 2  Imipinem / 
cilastatin     
   3002 12  000 3  Immunoglobulin 
G    
   3004 90 000 2  Ketamine     
   3004 20 000 2  Clarithramycin     
   3004 20  000 2  Clindamycin     
   3004 90 000 2  Lansoprazole     
   3004 20 000 2  Linezolid     
   3004 90 000 2  Loperamide     
   3004 90 000 2  Lorazepam     
   3004 20 000 2  Meropenem     
   3004 32  000 9  Methylprednisolo
ne    
   3004 90 000 2  Metoclopramide     
   3004 90 000 2  Midazolam     
   3004 49 000 9  Morphine     
   3004 90 000 2  Nadroparin     
   3004 90 000 2  Nifedipine     
   3004 39 000  Norepinephrine     
   2811 29  300 0  Nitric oxide       
  G/MA/QR/N/KGZ/1/Add.7  
 
- 6 - No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed 
Product 
Description  WTO Justification and 
Grounds for Restriction, 
e.g., Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modify  
cation of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   3004 90 000 2  Omeprazole     
   3004 90 000 2  Ondansetron     
   3004 90 000 2  Pantoprazole     
   3004 90 000 2  Paracetamol     
   3004 90 000 2  Pipecuronium     
   3004 10 000 8  Piperacillin / 
tazobactam     
   3004 32  000 9  Prednisolone     
   3004 90 000 2  Prenoxdiazine     
   3004 90 000 2  Propofol     
   3004 90 000 2  Ringer's solution     
   3004 90 000 2  Ringer's solution 
lactate     
   3004 90 000 2  Rivaraxaban     
   3004 90 000 2  Salbutamol     
   3002 12 000 5  Fresh frozen 
plasma     
   3004 90 000 2  Streptokinase     
   3004 90 000 2  Suxamethonium     
   3004 90 000 2  Tranexamic acid     
   3004 90 000 2  Famotidine     
   3004 90 000 2,  
2922 50  000 0  Phenylephrine     
   3004 90 000 2  Fentanyl     
   3004 90 000 2  Fluconazole     
   3004 90 000 2  Fondaparinux     
   3004 20 000 2  Cefepim     
   3004 20 000 2  Cefepime / 
sulbactam     
   3004 20 000 2  Cefotaxime     
   3004 20 000 2  Ceftazidime     
   3004 20 000 2,  
3004 90 000 2  Ceftaroline     
   3004 20 000 2  Ceftriaxone     
   3004 20 000 2  Cefuroxime     
   3004 20 000 2  Ciprofloxacin     
   3004 90 000 2  Edoxaban     
   3004 90 000 2  Enoxaparin     
   3004 39 000  Epinephrine       
  G/MA/QR/N/KGZ/1/Add.7  
 
- 7 - No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed 
Product 
Description  WTO Justification and 
Grounds for Restriction, 
e.g., Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modify  
cation of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   3004 90 000 2  Protamine 
sulfate     
   2804 40  000 0  Medical oxygen     
    2. Medical 
devices     
   9019 20 000 0  BPAP ventilator     
   9019 20 000 0  CPAP machine     
   9018 90 840 9  Bobrov's 
apparatus     
   9018 90 100 0  Blood pressure 
monitor 
(tonometer)     
   9019 20 000 0  Ventilator     
   9018 12  000 0  Ultrasound 
machine     
   9018 11 000 0  ECG machine     
   9018 12  000 0  Echocardiogram 
machines     
   9022 14 000 0  Stationary X -ray 
apparatus     
   9022 14 000 0  Mobile X -ray 
machine     
   3926 90 970 9,  
9018 90 840 9  Box for 
transportation of 
patients infected 
with dangerous 
viral infections     
   3005 90 100 0  Medical cotton 
wool    
   9018 90  840 9  Guedel airway 
kit, sterile, 
disposable 
(several sizes)     
   9027 10 900 0,  
9018 90 840 9  Gas analyzers     
   9027 80 170 0,  
9018 90 840 9  Blood glucose 
meter with test 
strips     
   8514 30 000 0  Destructor for 
needles       
  G/MA/QR/N/KGZ/1/Add.7  
 
- 8 - No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed 
Product 
Description  WTO Justification and 
Grounds for Restriction, 
e.g., Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modify  
cation of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   9018 90 840 9  Defibrillator     
   6210 10  980 0  Medical 
protective suit     
   9018 39  000 0  
9018 90  840 9  Sterile swab     
   9018 39 000 0  Syringe needles 
(wide bore)     
   9019 20 000 0  Inhaler 
ultrasound     
   9018 90 500 9  Drip infusion 
pump     
   9018 90 500 9  Syringe infusion 
pump     
   9018 19 100 0  Capnographer     
   8539 49  000 0  Germicidal lamp     
   9019 20 000 0  Oxygen 
concentrator     
   9022 12  000 0  Computer 
tomograph     
   9018 90 200 0,  
9018 90 840 9  Laryngoscope     
   3005 10 000 0  Adhesive plaster     
   3005 90 310 0  Gauze     
   6307 90 980 0,  
4818 90 900 0,  
4818 90 100 0,  
3005 90 500 0  Mask, half mask, 
respirator mask, 
respirator     
   9019 20 000 0  Reservoir bag 
masks     
   9402 90 000 0  Medical furniture 
(bed + 
curbstone + 
table)     
   9402 90 000 0  Medical 
instrument 
trolleys     
   8443 32  100 9  
9006 59  000 8  Medical X -ray 
Printer       
  G/MA/QR/N/KGZ/1/Add.7  
 
- 9 - No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed 
Product 
Description  WTO Justification and 
Grounds for Restriction, 
e.g., Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modify  
cation of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   9018 90 840 9  Stainless Steel 
Tongue 
Depressor Set     
   3822 00 000 0,  
3002 19 000 0  Coronavirus test 
kit    
   9018 39 000 0  Nasal cannulas     
   9019 20  000 0  Nebulizer     
   9018 39 000 0  Oxygen therapy 
nasopharyngeal 
catheters     
   3926 20 000 0  
4015 19  000 0  Inspection 
gloves     
   4015 11 000 0  Surgical gloves     
   9020 00  000 0  Oxygen Therapy 
Full Face Mask     
   9018 19 100 0  Bedside monitor     
   9018 19 100 0  Pulse Oximeter     
   8419 89 981 0  Plasma defroster     
   3702 10  000 0  X-ray film for 
medical printer     
   9018 20 000 0  Bactericidal 
recirculator     
   9019 20 000 0  Manual 
breathing 
apparatus for 
adults     
   9019 20 000 0  Manual 
breathing 
apparatus for 
children     
   9018 90 500 9  Infusion systems     
   9018 90  500 1  Blood 
transfusion 
systems     
   9027 50 000 0  Thermal imager 
(portable)     
   9027 50 000 0  Thermal imager 
(stationary)     
   9025 19 200 0  Thermometer IR       
  G/MA/QR/N/KGZ/1/Add.7  
 
- 10 - No General description 
of the restriction  Type of 
restriction  
 Tariff line code(s) 
affected, based on 
HS (2012)  Detailed 
Product 
Description  WTO Justification and 
Grounds for Restriction, 
e.g., Other International 
Commitments  National legal 
basis and entry 
into force  
 Administration, modify  
cation of previously notified 
measures,  
and other comments  
 1 2 3 4 5 6 7 
   9402 90 000 0  Functional bed 
3-section     
   6203399000,  
621149  0009,  
6211321000,  
6210109800,  
6211431000  Medical gown, 
disposable     
   9018 90  840 9  Surgical suction     
   9018 39 000 0  Central venous 
catheters     
   9018 90 500 9  Blood collection 
syringes     
   9019 31 100 9  Injection 
syringes, single 
use    
   9018 90 840 9  IV stand     
   9018 90  840 9  Endotracheal 
tube without cuff     
   9018 90 840 9  Cuffed tracheal 
tube    
 
__________